中國巨石(600176.SH):1-2月利潤總額同比增長60%以上
格隆匯3月9日丨中國巨石(600176.SH)公佈,2022年1-2月,玻璃纖維全行業延續了2021年的行業高景氣形勢。受益於新能源汽車銷量增長帶來的輕量化產品需求增長、風電等可再生能源行業增長帶來的高強高模產品增長、國內經濟穩增長拉動下的基建項目帶來的大類玻纖產品需求提升,國內外粗紗市場均呈現需求向上態勢,特別是歐美等海外市場需求旺盛,公司主流粗紗產品供不應求。
截止目前,公司國內外生產基地產能滿負荷運行,粗紗產銷率維持高位,庫存水平繼續維持歷史低位,銷售價格環比穩中有升,生產經營狀況穩中向好,2022年1-2月份利潤總額同比增長60%以上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.